About ICIS ICIS is part of Lexis Nexis Risk a division of RELX Group, a FTSE 20 company with revenues of $12.9 billion in 2025 and an employee base of over 30,000 people across 40 countries.
Overview Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable
About ICIS ICIS is part of Lexis Nexis Risk a division of RELX Group, a FTSE 20 company with revenues of $12.9 billion in 2025 and an employee base of over 30,000 people across 40 countries.